26 results on '"Tranylcypromine"'
Search Results
2. LENGTH OF HOSPITALIZATION WITH VARIOUS TREATMENTS FOR DEPRESSION.
3. Combined tranylcypromine-trifluoperazine therapy in the treatment of patients with agitated depressions.
4. TOXIC REACTIONS TO TRANYLCYPROMINE.
5. COMBINED TRANYLPROMINE-TRIFLUOPERAZINE THERAPY INNEWLY ADMITTED DEPRESSED PATIENTS.
6. Peripheral edema and tachycardia during tranylcypromine therapy.
7. Severe hypertension with parnate.
8. Tranylcypromine and trifluoperazine in the treatment of dangerous hospitalized patients.
9. HYPERTENSION WITH METHIONINE IN SCHIZOPHRENIC PATIENTS RECEIVING TRANYLCYPROMINE.
10. PSYCHOPHARMACOLOGY AND PHYSIOLOGICAL TREATMENT.
11. Tranylcypromine in the treatment of chronic schizophrenics.
12. The unique therapeutic properties of tranylcypromine and trifluoperazine (parstelin).
13. Successful suicide with tranylcypromine sulfate.
14. Trifluoperazine and Tranylcypromine in chronic refractory schizophrenics.
15. The use of Parnate in the treatment of depression.
16. VASCULAR CRISES ASSOCIATED WITH MONOAMINE-OXIDASE INHIBITORS.
17. The prediction of response to tranylcypromine plus trifluoperazine by the MMPI.
18. TRANYLCYPROMINE WITH ECT.
19. Tranylcypromine (parnate) a new monoamine oxidase inhibitor.
20. COMBINED DRUG THERAPY COMPARED WITH ELECTRIC SHOCK IN PSYCHOTIC DEPRESSIONS.
21. Tranylcypromine in depression: a clinical report.
22. The relative merits of tranylcypromine alone and tranylcypromine in combination with trifluoperazine in the treatment of patients with severe agitated depressions.
23. Tranylcypromine (Parnate) in the ambulatory treatment of depressed patients.
24. HYPERTENSION AND TRANYLCYPROMINE.
25. PATIENTS' RESPONSE TO TRANYLCYPROMINE WITHDRAWAL.
26. The use of stelazine and parnate in chronic, withdrawn patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.